Deans' stroke musings: Synchron launches patient registry for Stentrode brain-computer interface

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, April 10, 2024

Synchron launches patient registry for Stentrode brain-computer interface

FYI.

Synchron launches patient registry for Stentrode brain-computer interface

Synchron has announced the launch of a community-centred brain-computer interface (BCI) registry to bring patients, carers and clinicians together to learn how BCI technology is being designed to provide benefit to people with limited mobility.

Stentrode device

Synchron’s BCI technology—primarily seen in the company’s Stentrode device—is designed to decipher the neural code of the brain and find new ways to restore motor intent to control digital devices. The Synchron BCI represents a novel approach to restoring functionality in patients with limited mobility, according to a company press release. By leveraging an individual’s blood vessels, the device is implanted in the brain without the need for invasive brain surgery.

“We are thrilled to launch our community-centred BCI registry,” said Tom Oxley, chief executive officer and founder, Synchron. “There is a grass roots movement happening with BCI. We are creating an avenue for potential users and their physicians to engage, and stay connected, while we prepare for the next stage of clinical trials.”

“BCI technology enables individuals with motor impairment to regain independence,” said principal investigator David Lacomis (University of Pittsburgh, Pittsburgh, USA). “By controlling digital devices through one’s own thoughts, BCI offers a transformative path towards performing daily tasks with greater ease and efficiency. From communication to accessing essential services online, BCI technology represents a groundbreaking frontier for individuals and their families.”